胰岛素市场战略、顶级参与者、增长机会、2028 年分析和预测

  • Report Code : TIPRE00004051
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 186
Buy Now

Insulin Market Share Report – Global Size Outlook 2022-2028

Buy Now

 

[研究报告] 胰岛素市场预计将从 2022 年的 601.8309 亿美元增长至 2028 年的 1112.1373 亿美元;预计 2022-2028 年胰岛素市场的复合年增长率为 10.8%。     

 

 

分析师观点:

糖尿病患病率的上升和药物输送设备技术的不断进步正在推动胰岛素市场的增长。例如:2020 年 5 月,Biocon 在美国以小瓶和预填充笔的形式推出了 Semglee。该产品在美国市场上以所有长效胰岛素 Gargline 中最低的批发采购成本 (WAC) 提供。此外,新产品的推出是推动市场增长的另一个驱动因素。例如:Novo Nordisk 宣布以片剂形式推出 GLP-1 注射糖尿病药物。这种口服药物还将帮助患者减轻体重并降低心脏病风险。2022 年,北美拥有最大的胰岛素市场份额,其次是欧洲。此外,由于糖尿病患者数量庞大且人们对生活方式障碍的认识不断提高,预计亚太地区将以最高的复合年增长率增长,医疗保健支出的增加有助于促进该地区的胰岛素市场增长。

 

市场概况:

 

胰岛素是一种有助于降低血糖水平的激素。胰岛素疗法通常是糖尿病治疗的重要组成部分。它由胰腺的β细胞产生,当血糖水平升高时(例如进食后)释放到血液中。胰岛素帮助葡萄糖进入体细胞,这些细胞可以用作能量或储存以备将来使用。不同类型的胰岛素在控制血糖的速度和持续时间上有所不同。胰岛素不是药丸形式,因为消化系统会在它发挥作用之前将其分解。胰岛素疗法很累人;然而,它是一种有效的降低血糖水平的方法。

推动胰岛素市场增长的关键因素是糖尿病发病率的上升以及胰岛素给药装置技术的快速发展,这些都是推动胰岛素市场增长的主要因素。然而,与胰岛素给药装置相关的风险预计将在预测期内制约胰岛素市场的增长。欧洲在全球胰岛素市场中占据第二位,预计在预测期内将实现强劲的增长率。1 型和 2 型糖尿病发病率的上升、胰岛素需求的增加以及政府对糖尿病治疗的有利举措可能是推动该地区胰岛素市场增长的主要因素。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

胰岛素市场:

胰岛素市场
  • Insulin Market
    复合年增长率(2022 - 2028)
    10.8%
  • 2022 年市场规模
    601.8 亿美元
  • 2028 年市场规模
    1112.1 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • 礼来公司
  • 诺和诺德公司
  • 比奥康
  • 沃克哈特
  • 阿多西亚
  • 葛兰素史克公司
  • 赛诺菲
  • 辉瑞
  • 默克公司

区域概况

Insulin Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Insulin Market类型
  • 长效胰岛素
  • 速效胰岛素
  • 短效胰岛素和传统人类胰岛素
  • 浓缩胰岛素和组合胰岛素
  • 生物仿制药胰岛素
  • 胰高血糖素样肽-1
Insulin Market地理
  • 北美
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 南美洲和中美洲
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

 

市场驱动因素:

 

 

主要参与者在胰岛素输送装置技术方面的快速发展推动了胰岛素市场的增长

具有先进胰岛素技术且功效更有效的产品是治疗糖尿病的主要需求。过去几年,糖尿病治疗取得了长足进步。随着糖尿病在世界范围内的流行,对更先进产品的需求也在增加。由于行业参与者的战略努力增加,胰岛素市场预计将增长。市场参与者积极支持其公共和私人研究和学术机构增加研究活动。

以下是与胰岛素市场快速技术进步相关的一些最新发展:

  • 2022 年 5 月,礼来公司获得美国食品药品监督管理局 (FDA) 批准其 Mounjar (tirzepatide) 每周一次的葡萄糖依赖性胰岛素促泌多肽 (GIP) 和 GLP-1 胰高血糖素样肽-1 (GLP-1) 受体激动剂,用于治疗患有 2 型糖尿病的成年人。该注射剂决定以六种剂量(2.5 毫克、5 毫克、7.5 毫克、10 毫克、12.5 毫克和 15 毫克)的形式提供,采用带有预装隐藏针头的自动注射笔。
  • 2021年10月,Adocia宣布其合作伙伴通化冬布亚药业有限公司获得中国国家药品监督管理局(NMPA)药品审评中心(CDE)的批准,开展BioChaperone Lispro和Ultra-Rapid Insulin用于治疗1型和2型糖尿病的3期临床试验
  • 2021年10月,通化东宝药业股份有限公司超速效胰岛素注射液BC Lispro获得国家药品监督管理局临床试验批准,目前该药物正在中国启动III期临床试验。
  • 2021 年 5 月,Bigfoot Biomedical 的 Bigfoot Unity 糖尿病管理系统获得了美国食品药品监督管理局 (FDA) 的 510(k) 批准,该系统具有联网的智能笔帽,可为采用每日多次注射 (MDI) 疗法的患者推荐胰岛素剂量。

因此,胰岛素输送装置技术的快速进步正在推动全球胰岛素市场的增长。

 

细分分析:

根据类型,胰岛素市场细分为长效胰岛素、速效胰岛素、短效胰岛素和传统人类胰岛素、浓缩胰岛素和组合胰岛素、生物仿制药胰岛素、胰高血糖素样肽-1 (GLP-1)、注射笔和针头等。长效胰岛素细分市场预计将在 2021 年占据最大的市场份额,而生物仿制药胰岛素细分市场预计将在预测期内实现 16.0% 的最高复合年增长率。生物仿制药胰岛素细分市场增长的主要驱动因素是近交系小鼠在心血管和免疫学研究中的应用增加以及单克隆抗体的生产等。长效胰岛素类似物是经过基因工程改造的。长效胰岛素类似物最初是为了满足糖尿病患者整晚保持健康血糖水平的需求而开发的。由于其酸性 pH 值,这种胰岛素会缓慢释放到血液循环中,导致其在皮下注射时沉淀。长效胰岛素也称为基础胰岛素或背景胰岛素。它们在后台持续工作,以在日常生活中控制血糖。这些长效胰岛素有助于控制一整天的血糖。这类似于胰腺产生胰岛素以维持两餐之间的血糖水平。国家医疗服务体系 (NHS) 青睐长效胰岛素类似物,因为这些胰岛素没有峰值活性,因此可以全天持续发挥作用。

Tresiba 是一种长效胰岛素,用于控制患有糖尿病的成人和 1 岁及以上儿童的高血糖水平。它不适合患有糖尿病酮症酸中毒的人。Tresiba 含有活性成分胰岛素德谷。Tresiba 通常每天在一天中的任何时间皮下注射一次。长效胰岛素全天持续发挥作用,控制两餐之间和夜间的血糖。它有两种浓度,即 200 单位/毫升和 100 单位/毫升。Tresiba 以多剂量小瓶或 FlexTouch 笔的形式提供,供单个患者使用。Tresiba FlexTouch 是一种一次性预填充笔,有两种不同强度,U-100(100 单位/毫升)含有 300 单位胰岛素,U-200(200 单位/毫升)含有 600 单位胰岛素。Tresiba 不得与胰岛素泵一起给药或与其他胰岛素混合使用。 Tresiba 的常见副作用包括低血糖、过敏反应、注射部位反应、脂肪营养障碍、瘙痒、皮疹、水肿和体重增加。

 

区域分析:

北美拥有最大的胰岛素市场,2022 年价值 239.4685 亿美元,复合年增长率为 10.5%。由于各国糖尿病患病率显著上升、肥胖患病率高以及该地区对糖尿病护理的认识不断提高,预计北美将继续保持这一地位。在北美,美国在 2022 年占据胰岛素市场的最大市场份额,为 84.88%。美国医疗保健系统正在见证大量投资新产品的推出。此外,胰岛素市场的增长归因于产品开发的增加和政府对糖尿病治疗的支持不断增加。此外,该国糖尿病新病例的增加也提供了有利的增长机会。例如,根据《2020 年国家糖尿病统计报告》,美国约有 3030 万人患有糖尿病,占总人口的 94%。在糖尿病患者中,近 5% 的人口被诊断患有 1 型糖尿病,而 90-95% 的人患有 2 型糖尿病。在 3000 多万患有糖尿病的美国人中,约有 740 万人依靠胰岛素来控制病情。此外,数据还显示,约有 8600 万 18 岁或以上的成年人处于糖尿病前期,近 2310 万 65 岁以上的老年人处于糖尿病前期。在美国,糖尿病是导致成年人失明和肾病末期或肾衰竭的主要原因。此外,医疗设施网络的扩大和医疗旅游可能会加速墨西哥胰岛素市场的增长。

然而,亚太地区 (APAC) 是胰岛素增长最快的区域市场。亚太地区的市场分为中国、印度、日本、韩国、澳大利亚和亚太地区其他地区。全球糖尿病患病率的不断上升以及肥胖等生活方式相关疾病发病率的上升预计将在未来六年推动市场增长。胰岛素针对的是糖尿病患者群体。患病率的快速增长预计将在预测期内显著影响市场增长。此外,强大的产品线组合和这些产品的未来商业化预计将为该市场提供未来的增长机会。

 

关键球员分析:

 

其中包括 Eli Lily and Company;Novo NordiskA/S;Biocon;Wockhardt;Adocia;GlaxoSmithKline plc;Sanofi;Pfizer;Merck &Co., Inc.;通化东宝药业股份有限公司和 Bigfoot Biomedical, Inc.。Novo NordiskA/S. 和 Sanofi 是胰岛素市场的两大参与者。Novo Nordisk 是一家欧洲公司,总部位于丹麦。该公司专注于提供肥胖症、血友病、生长障碍和其他严重慢性疾病的治疗。该公司专注于许多治疗领域,例如 1 型糖尿病、2 型糖尿病、肥胖症、动脉粥样硬化、NASH、血友病和生长障碍。该公司通过其子公司开展业务,例如 Ziylo Ltd、MB2 LLC、Novo Nordisk Pharmaceuticals Limited、Novo Nordisk Pharma, Sa 等。该公司还提供糖尿病、肥胖症以及罕见血液病和内分泌疾病的治疗。

 

胰岛素市场报告范围

报告属性细节
2022 年市场规模601.8亿美元
2028 年市场规模1112.1亿美元
全球复合年增长率(2022 - 2028)10.8%
历史数据2020-2021
预测期2023-2028
涵盖的领域按类型
  • 长效胰岛素
  • 速效胰岛素
  • 短效胰岛素和传统人类胰岛素
  • 浓缩胰岛素和组合胰岛素
  • 生物仿制药胰岛素
  • 胰高血糖素样肽-1
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 礼来公司
  • 诺和诺德公司
  • 比奥康
  • 沃克哈特
  • 阿多西亚
  • 葛兰素史克公司
  • 赛诺菲
  • 辉瑞
  • 默克公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

 

最近的发展:

 

胰岛素市场中的公司大量采用并购等无机和有机战略。以下列出了一些近期的关键市场发展: 

  • 2022 年 6 月,赛诺菲与 Health2Sync 签署合作协议,将胰岛素管理数字解决方案引入日本。两家公司将共同开发日本胰岛素的数字化功能,例如胰岛素连接帽和滴定警报。
  • 2022 年 6 月,赛诺菲宣布,公司将把针对无保险美国人的胰岛素月费上限从 99 美元降至 35 美元。该公司将以 35 美元的价格向无保险人群销售 Lantus Insulin Glargine U-100、Toujeo、Admelog 和 Apidra 等胰岛素,30 天的供应量为 35 美元。
  • 2022 年 1 月,默克公司宣布延长欧盟二甲双胍产品(如 Glucophage、Glucophage XR 和 Stagid)的标签范围,以供整个妊娠期使用。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region is dominating the insulin market?

The global insulin market based on regions is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In 2021, the North American region held the largest market share. However, the Asia Pacific region is estimated to grow at the fastest CAGR of 12.7% during the forecast period

What are the restraining factors for the global insulin market worldwide?

Risks associated with insulin delivery devices are expected to restrict the insulin market growth during the forecast period.

What is insulin?

Insulin controls the body's fat and glucose metabolism. It is a peptide hormone that is secreted by beta cells in the islets of Langerhans in the pancreas and helps in glucose metabolism regulation. It promotes glucose to be absorbed from the blood by skeletal muscle cells and fat tissues. But due to some diseases and disorders body is not able to make a sufficient amount of insulin which results in hyperglycemia due to imbalanced metabolism. In such conditions, insulin is given externally to maintain normal blood glucose levels.

What are the driving factors for the global insulin market worldwide?

The factors driving the growth of the insulin market are the increase in the incidence of diabetes and rapid technological developments in insulin delivery devices by major players.

Who are the major players in the insulin market across the globe?

The insulin market majorly consists of the players, such as Eli Lilly and Company; Novo Nordisk A/S; Biocon; WOCKHARDT; Adocia; GlaxoSmithKline plc.; Sanofi; Pfizer Inc.; Merck & Co., Inc.; Tonghua Dongbao Pharmaceutical Co., Ltd.; BIGFOOT BIOMEDICAL, INC.; among others.

Which segment is dominating the insulin market?

The global insulin market based on type is segmented into long-acting insulin, rapid-acting insulin, short-acting insulin & traditional human insulin, concentrated insulin & combination insulin, biosimilar insulin, glucagonlike-peptide-1 (glp-1), pens & needles, and others. In 2021, the long-acting insulin segment held the largest share of the market. However, the biosimilar insulin segment of the insulin market is expected to register the highest CAGR of 16.0% during the forecast period.

The List of Companies - Insulin Market

  1. Eli Lily and Company
  2. Novo NordiskA/S
  3. Biocon
  4. Wockhardt
  5. Adocia
  6. GlaxoSmitheKline plc
  7. Sanofi
  8. Pfizer
  9. Merck &Co., Inc.
  10. Tonghua Dongbao Pharmaceutical Co., Ltd.
  11. Bigfoot Biomedical, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..